Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.

Oklahoma City, Oklahoma, UNITED STATES

OKLAHOMA CITY, June 04, 2018 (GLOBE NEWSWIRE) -- On April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of Utah against Myriad Genetics, Inc. (NASDAQ:MYGN).  Federman & Sherwood reminds current and former shareholders of Myriad Genetics, Inc. that they only have until Tuesday, June 19, 2018 to move the court for appointment as a lead plaintiff in this case.  The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased Myriad Genetics, Inc. shares between August 13, 2014 and March 12, 2018, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible.  Our firm seeks to recover damages on behalf of the Class.  Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud.  We represent investors throughout the country in shareholder litigation.

William B. Federman
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560/Fax: (405) 239-2112
Email to: wbf@federmanlaw.com - www.federmanlaw.com